Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD

ClinicalTrials.gov ID: NCT00499590

Public ClinicalTrials.gov record NCT00499590. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 7:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-masked, Parallel-assignment Study of Intravitreal Bevasiranib Sodium, Administered Every 8 or 12 Weeks as Maintenance Therapy Following Three Injections of Lucentis® Compared With Lucentis® Monotherapy Every 4 Weeks in Patients With Exudative Age-Related Macular Degeneration (AMD).

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety and effectiveness of bevasiranib given either every 8 weeks or every 12 weeks after an initial pre-treatment with 3 injections of Lucentis® (ranibizumab injection) compared to Lucentis® given every 4 weeks to people with wet AMD. Patients will be assigned at random (like tossing a coin) to receive one of three treatments options for 104 weeks.

Study identification

NCT ID
NCT00499590
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
OPKO Health, Inc.
Industry
Enrollment
338 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2007 (Type not available)
Primary completion
Mar 2009 (Actual)
Completion
May 2009 (Actual)
Last update posted
Oct 6, 2014

2007 – 2009

United States locations

U.S. sites
55
U.S. states
24
U.S. cities
50
Facility City State ZIP Site status
Retinal Consultants of Arizona (site 209) Phoenix Arizona 85014 —
Associated Retina Consultants (site 286) Phoenix Arizona 85020 —
Retina Centers PC (site 215) Tucson Arizona 85704 —
Eye Medical Center (site 287) Fresno California 93720 —
Northern California Retina Vitreous Associates (site 320) Mountain View California 94040 —
Retina Institute of California (site 207) Pasadena California 91105 —
Retina Consultants San Diego (site 232) Poway California 93064 —
Retinal Consultants Medical Group (site 289) Sacramento California 95819 —
Orange County Retina Medical Group (site 252) Santa Ana California 92705 —
Miramar Eye Specialists Medical Group (site 245) Ventura California 93003 —
The Eye Care Group, PC (site 315) Waterbury Connecticut 06708 —
Florida Eye Clinic (site 257) Altamonte Springs Florida 32701 —
Florida Eye Microsurgical Institute, Inc. (site 217) Boynton Beach Florida 33426 —
Retina Health Center (site 247) Fort Myers Florida 33901 —
National Ophthalmic Research Institute at Retina Consultants of SW Florida (site 270) Fort Myers Florida 33912 —
Magruder Eye Institute (site 264) Orlando Florida 32803 —
Southern Vitreoretinal Associates, PL (site 309) Tallahassee Florida 32308 —
University of South Florida Eye Institute (site 311) Tampa Florida 33612 —
Center for Retina and Macular Disease (site 293) Winter Haven Florida 33880 —
Southeast Retina Center (site 268) Augusta Georgia 30909 —
Midwest Eye Institute (site 253) Indianapolis Indiana 46280 —
Retina Associates, PA (site 295) Shawnee Mission Kansas 66204 —
Vitreo-Retinal Consultants & Surgeons, P.A. (site 274) Wichita Kansas 67214 —
Eye Centers of Louisville (site 251) Louisville Kentucky 40207 —
Retina Specialists (site 231) Towson Maryland 21204 —
Retina Associates St. Louis (site 300) Florissant Missouri 63031 —
Eye Foundation of Kansas City Truman Medical Center (site 272) Kansas City Missouri 64108 —
Retinal Consultants of Nevada (site 273) Las Vegas Nevada 89144 —
Eyesight Ophthalmic Services, PA (site 290) Portsmouth New Hampshire 03801 —
Delaware Valley Retina Associates (site 261) Lawrenceville New Jersey 08648 —
Retina-Vitreous Consultants (site 216) Livingston New Jersey 07039 —
Retina Associates of New Jersey (site 298) Teaneck New Jersey 07666 —
Capital Region Retina (site 316) Albany New York 12206 —
New York Eye & Ear Infirmary (site 272) New York New York 10003 —
Vitreous-Retina-Macula Consultants of New York (site 239) New York New York 10022 —
Carolina Eye Associates (site 308) Southern Pines North Carolina 28387 —
Retina Associates of Cleveland (site 228) Beachwood Ohio 44122 —
Cincinnati Eye Institute (site 285) Cincinnati Ohio 45242 —
Retina Associates of Cleveland, Inc. (site 219) Lakewood Ohio 44107 —
Retina-Vitreous Associates (site 266) Toledo Ohio 43608 —
Retina and Vitreous Center of Southern Oregon (site 271) Ashland Oregon 97520 —
Ophthalmology Associates of PA (site 297) Bala-Cynwyd Pennsylvania 19004 —
Palmetto Retina Center (site 275) West Columbia South Carolina 29169 —
Black Hills Regional Eye Institute (site 202) Rapid City South Dakota 57701 —
Southeastern Retina Associates, PC (Site 250) Knoxville Tennessee 37909 —
Retina Research Institute of Texas, L.L.C. (site 269) Abilene Texas 79606 —
Austin Retina Associates (site 304) Austin Texas 78705 —
Retina Research Center (site 204) Austin Texas 78705 —
University of Texas Medical Branch- Galveston (site 301 Galveston Texas 77555 —
Houston Eye Associates (site 321) Houston Texas 77025 —
Valley Retina Institue, PA (site 258) McAllen Texas 78503 —
Eye Care Associates of East Texas (site 282) Tyler Texas 75701 —
Rocky Mountain Retina Consultants (site 256) Salt Lake City Utah 84107 —
University of Utah, John A. Moran Eye Center (site 205) Salt Lake City Utah 84132 —
University of Virginia- Ophthalmology Dept. (site 254) Charlottesville Virginia 22908 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00499590, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 6, 2014 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00499590 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →